These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 12611080

  • 1. VEGFs, angiopoietins, Ephrins and their receptors: putative targets for tumor therapy?
    Marmé D.
    Ann Hematol; 2002; 81 Suppl 2():S66. PubMed ID: 12611080
    [No Abstract] [Full Text] [Related]

  • 2. Double target for tumor mass destruction.
    Saharinen P, Alitalo K.
    J Clin Invest; 2003 May; 111(9):1277-80. PubMed ID: 12727916
    [No Abstract] [Full Text] [Related]

  • 3. The biology of VEGF and its receptors.
    Ferrara N, Gerber HP, LeCouter J.
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [Abstract] [Full Text] [Related]

  • 4. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
    Breier G, Heidenreich R, Gaumann A, Groot M, Licht A, Nicolaus A, Schmitz J, Reichmann E, Plate KH, Vajkoczy P.
    Ann Hematol; 2002 Jun; 81 Suppl 2():S71-2. PubMed ID: 12611084
    [No Abstract] [Full Text] [Related]

  • 5. [Neoplasms and angiogenesis].
    Lewy-Trenda I.
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [Abstract] [Full Text] [Related]

  • 6. The molecular perspective: VEGF and angiogenesis.
    Goodsell DS.
    Stem Cells; 2003 Sep; 21(1):118-9. PubMed ID: 12529559
    [No Abstract] [Full Text] [Related]

  • 7. Molecular control of physiological skin angiogenesis.
    Odorisio T, Failla CM, Zambruno G.
    Eur J Dermatol; 2002 Sep; 12(6):VII-X. PubMed ID: 12506892
    [No Abstract] [Full Text] [Related]

  • 8. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 9. Biomedical significance of endothelial cell specific growth factor, angiopoietin.
    Koh GY, Kim I, Kwak HJ, Yun MJ, Leem JC.
    Exp Mol Med; 2002 Mar 31; 34(1):1-11. PubMed ID: 11989972
    [Abstract] [Full Text] [Related]

  • 10. [Role of receptor tyrosine kinase in the angiogenesis].
    Meyer S, Hafner C, Vogt T.
    Hautarzt; 2002 Sep 31; 53(9):629-42. PubMed ID: 12432901
    [No Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I.
    IDrugs; 2003 Mar 31; 6(3):224-31. PubMed ID: 12789611
    [Abstract] [Full Text] [Related]

  • 12. VEGF and the quest for tumour angiogenesis factors.
    Ferrara N.
    Nat Rev Cancer; 2002 Oct 31; 2(10):795-803. PubMed ID: 12360282
    [Abstract] [Full Text] [Related]

  • 13. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
    Rafii S, Lyden D, Benezra R, Hattori K, Heissig B.
    Nat Rev Cancer; 2002 Nov 31; 2(11):826-35. PubMed ID: 12415253
    [No Abstract] [Full Text] [Related]

  • 14. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
    Joussen AM, Kirchhof B, Gottstein C.
    Ophthalmologe; 2003 Apr 31; 100(4):284-91. PubMed ID: 12682760
    [Abstract] [Full Text] [Related]

  • 15. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
    Fahmy RG, Dass CR, Sun LQ, Chesterman CN, Khachigian LM.
    Nat Med; 2003 Aug 31; 9(8):1026-32. PubMed ID: 12872165
    [Abstract] [Full Text] [Related]

  • 16. Neuroblastoma, apoptosis, and growth factors.
    Beierle EA, Dai W, Langham MR, Chen MK.
    Am Surg; 2003 Jan 31; 69(1):28-31. PubMed ID: 12575776
    [Abstract] [Full Text] [Related]

  • 17. Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation.
    Gale NW, Thurston G, Davis S, Wiegand SJ, Holash J, Rudge JS, Yancopoulos GD.
    Cold Spring Harb Symp Quant Biol; 2002 Jan 31; 67():267-73. PubMed ID: 12858549
    [No Abstract] [Full Text] [Related]

  • 18. The clinical implications of angiogenesis in the treatment of cancer.
    Aoun E, Taher A.
    J Med Liban; 2002 Jan 31; 50(1-2):32-8. PubMed ID: 12841311
    [Abstract] [Full Text] [Related]

  • 19. Advances in the use of angiogenesis inhibitors in cancer.
    Pinedo HM.
    Cancer J; 2001 Jan 31; 7 Suppl 3():S107-8. PubMed ID: 11779080
    [No Abstract] [Full Text] [Related]

  • 20. Expressions of vascular endothelial growth factor and angiopoietin-2 in myeloma cells.
    Uneda S, Matsuno F, Sonoki T, Tniguchi I, Kawano F, Hata H.
    Haematologica; 2003 Jan 31; 88(1):113-5. PubMed ID: 12551836
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.